DelMar Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
26 Contracts & Agreements
- Form of Option Agreement under the Amended and Restated Equity Plan of Morphogenesis, Inc (Filed With SEC on May 13, 2024)
- Amended and Restated Equity Plan of Morphogenesis, Inc (Filed With SEC on May 13, 2024)
- Form of Lock-Up Agreement (Filed With SEC on April 3, 2024)
- Form of TuHURA Support Agreement (Filed With SEC on April 3, 2024)
- Form of Contingent Value Rights Agreement (Filed With SEC on April 3, 2024)
- Form of Kintara Support Agreement (Filed With SEC on April 3, 2024)
- Engagement Agreement, dated September 10, 2021 (Filed With SEC on September 28, 2021)
- Description of Securities (Filed With SEC on September 18, 2020)
- Form of Adgero Support Agreement (Filed With SEC on June 16, 2020)
- Form of DelMar Support Agreement (Filed With SEC on June 16, 2020)
- Form of Adgero Support Agreement (Filed With SEC on June 10, 2020)
- Form of DelMar Support Agreement (Filed With SEC on June 10, 2020)
- Form of Leak-Out Agreement, dated as of August 14, 2019 (Filed With SEC on August 15, 2019)
- Form of Dealer Manager Agreement (Filed With SEC on May 23, 2019)
- Form of Leak-Out Agreement, dated as of November 25, 2018, by and between DelMar Pharmaceuticals, Inc. and the Exercising Holders (Filed With SEC on November 26, 2018)
- Agreement, effective as of November 3, 2017 between the Company and Mr. Zarrabian (Filed With SEC on November 8, 2017)
- Engagement Letter, dated September 17, 2017 between DelMar Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on September 21, 2017)
- 430 Park Avenue| New York, New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC (Filed With SEC on April 13, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 13, 2017)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on February 10, 2017)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on February 10, 2017)
- DELMAR PHARMACEUTICALS, INC. ROYALTYAGREEMENT (Filed With SEC on May 5, 2016)
- DELMARPHARMACEUTICALS, INC. SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 5, 2016)
- DELMAR PHARMACEUTICALS, INC. AUDIT COMMITTEE CHARTER A. Purpose and Scope (Filed With SEC on September 3, 2015)
- U.S.SUBSCRIPTION AGREEMENT (Filed With SEC on July 9, 2015)
- ESCROWAGREEMENT (PUBLIC OFFERING) (Filed With SEC on June 23, 2015)
